Amrubicin CAS:110267-81-7, a potent anthracycline, effectively treats various cancers. This synthetic drug exhibits strong antitumor activity. It targets topoisomerase II, disrupting DNA replication. Amrubicin demonstrates fewer cardiotoxic effects compared to doxorubicin. The drug metabolizes into amrubicinol, increasing its efficacy. Administered intravenously, amrubicin is used for small cell lung cancer and relapsed aggressive non-Hodgkin lymphomas. Research on other malignancies continues.
Payloads and Linker modified Payloads
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。